ICU Medical Q4 2022 revenue $578M, GAAP net loss $15.5M, provides FY23 guidance

ICU MEDICAL INC/DE

2022-FY EPS reported -$3.11 revenue$2,279,997,000

Revenue $578.0M vs $340.5M YoY; GAAP net loss $(15.5)M ($(0.65)/diluted) vs net income $19.9M ($0.91) in Q4 2021.
Adjusted diluted EPS $1.60 vs $1.82 YoY; adjusted EBITDA $96.4M vs $64.2M.
GAAP gross margin 30% vs 37% YoY; gross profit $174.9M vs $127.5M.
Fiscal year 2023 guidance announced but specific numbers not included in the excerpt.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ICU MEDICAL INC/DE reported the fourth quarter of 2022 results: revenue $578.0 million, net income $(15.5) million, EPS $(0.65) per diluted share.

Period: the fourth quarter of 2022
Revenue: $578.0 million
Net income: $(15.5) million
EPS: $(0.65) per diluted share
Result: reported results

Exact text from the filing

Fourth quarter 2022 revenue was $578.0 million, compared to $340.5 million in the same period last year. GAAP gross profit for the fourth quarter of 2022 was $174.9 million, as compared to $127.5 million in the same period last year. GAAP gross margin for the fourth quarter of 2022 was 30%, as compared to 37% in the same period last year. GAAP net loss for the fourth quarter of 2022 was $(15.5) million, or $(0.65) per diluted share, as compared to GAAP net income of $19.9 million, or $0.91 per diluted share, for the fourth quarter of 2021.

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

ICU MEDICAL INC/DE filing history →

Source: SEC EDGAR

accession 0000883984-23-000007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.